RNA-Seq Blog Transcriptome Research & Industry News
Head and neck squamous cell carcinoma (HNSCC) is the sixth leading cancer by incidence worldwide and considering the recent EUROCARE-5 population-based study the 5-year survival rate of HNSCC patients in Europe ranges between 69% in localized cases and 34% in ...
Read More »Gene Expression Signatures for Cancer Patient Stratification: Are Results Ready for Clinical Application?
